SpaceX Reportedly Preparing Record-Breaking IPO Targeting $1.5 Trillion Valuation 
China Adds Domestic AI Chips to Government Procurement List as U.S. Considers Easing Nvidia Export Curbs 
Samsung SDI Secures Major LFP Battery Supply Deal in the U.S. 
GameStop Misses Q3 Revenue Estimates as Digital Shift Pressures Growth 
Indonesia–U.S. Tariff Talks Near Completion as Both Sides Push for Year-End Deal 
EssilorLuxottica Bets on AI-Powered Smart Glasses as Competition Intensifies 
Fed Rate Cut Signals Balance Between Inflation and Jobs, Says Mary Daly 
Moore Threads Stock Slides After Risk Warning Despite 600% Surge Since IPO 
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand 
ANZ Faces Legal Battle as Former CEO Shayne Elliott Sues Over A$13.5 Million Bonus Dispute 
SoftBank Eyes Switch Inc as It Pushes Deeper Into AI Data Center Expansion 
Gold Prices Slip Slightly in Asia as Silver Nears Record Highs on Dovish Fed Outlook 
Brazil Holds Selic Rate at 15% as Inflation Expectations Stay Elevated 
Wall Street Futures Dip as Broadcom Slides, Tech Weighed Down Despite Dovish Fed Signals 
Fed Near Neutral Signals Caution Ahead, Shifting Focus to Fixed Income in 2026 
Nvidia Develops New Location-Verification Technology for AI Chips 
SK Hynix Considers U.S. ADR Listing to Boost Shareholder Value Amid Rising AI Chip Demand 
Lotte Biologics unveiled a landmark $3 billion partnership with Incheon's city government, Lotte Corporation, and Incheon Free Economic Zone (IFEZ) to establish major biotech production plants in Songdo. This monumental move accelerates the biotech giant's ambitious aim of a combined production capacity of 360,000 liters by 2030.
Lotte Biologics said on Tuesday, June 20, that the MOU is its first step into building the facilities in the region. As per Korea Joongang Daily, the other parties in the project are Lotte Corporation and the Incheon Free Economic Zone (IFEZ).
The contract signing ceremony was held at the IFEZ HQ in Songdo, and executives of the companies were present, including Lotte Biologics’ CEO, Richard Lee; IFEZ’s commissioner, Kim Jin Young; Lotte Corp. president, Lee Hun Ki; and Mayor of Incheon Metropolitan City, Yoo Jeong Bok.
The construction of the production facilities is part of the biotech firm’s plan to erect three new factories that will have a combined production facility of 360,000 liters by the year 2030. The plan was first unveiled in January this year.
The industrial complex will also be a place where the start-up, Bio-Venture Initiative, is expected to open a plant and facilitate possible technological cooperation. Lotte Biologics is planning a groundbreaking event for the construction, and this may happen soon.
This agreement highlights the enthusiastic response from Incheon Metropolitan City and Incheon Free Economic Zone regarding LOTTE BIOLOGICS’ intention to establish a major presence in Songdo,” Lotte Biologic’s chief executive officer said in a press release. “With the goal of commencing construction on the Mega Plant within the year, LOTTE BIOLOGICS will actively cooperate with Incheon Metropolitan City and Incheon Free Economic Zone to swiftly facilitate a land purchase agreement, with the enthusiastic support of LOTTE Corporation.”
Photo by: Lotte Biologics Newsroom
